These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 823274

  • 1. Bacteriological, clinical, and pharmacological investigations with tobramycin in patients with serious urinary tract infection.
    Iván E, Cstáry KN.
    J Infect Dis; 1976 Aug; 134 Suppl():S153-5. PubMed ID: 823274
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Synergy between ticarcillin and tobramycin against Pseudomonas aeruginosa and Enterobacteriaceae in vitro and in vivo.
    Comber KR, Basker MJ, Osborne CD, Sutherland R.
    Antimicrob Agents Chemother; 1977 Jun; 11(6):956-64. PubMed ID: 406837
    [Abstract] [Full Text] [Related]

  • 5. [Tobramycin. Bacteriological studies and clinical activity in urinary and extra-urinary infections].
    Abbate GF, Alagia I, Gattoni A, Leonessa V, Manguso L, Altucci P.
    G Ital Chemioter; 1977 Jun; 24(1-2):33-7. PubMed ID: 615760
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical experience with tobramycin in the treatment of infections due to gram-negative bacilli.
    Carmalt ED, Cortez LM, Rosenblatt JE.
    Am J Med Sci; 1976 Jun; 271(3):285-95. PubMed ID: 820195
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparative clinical study of tobramycin and gentamicin.
    Klastersky J, Hensgens C, Henri A, Daneau D.
    Antimicrob Agents Chemother; 1974 Feb; 5(2):133-8. PubMed ID: 4599859
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The use of tombramycin in the management of severe infections. Clinical and pharmacological data.
    Baron D, Drugeon H, Nicolas F, Courtieu A.
    Eur J Intensive Care Med; 1976 Sep; 2(2):89-96. PubMed ID: 964273
    [Abstract] [Full Text] [Related]

  • 13. Clinical and laboratory study of tobramycin in the treatment of infections due to gram-negative organisms.
    Marrie TJ, Gurwith MJ, Ronald AR, Stiver HG, Lank B, Fox L.
    Can Med Assoc J; 1977 Jul 23; 117(2):138-43. PubMed ID: 406032
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of urinary tract infections due to Pseudomonas aeruginosa with cefsulodin.
    Elder HA, Roy I.
    Rev Infect Dis; 1984 Jul 23; 6 Suppl 3():S734-43. PubMed ID: 6443774
    [Abstract] [Full Text] [Related]

  • 17. Comparison of amikacin and tobramycin in the treatment of infection in patients with cancer.
    Feld R, Valdivieso M, Bodey GP, Rodriguez V.
    J Infect Dis; 1977 Jan 23; 135(1):61-6. PubMed ID: 401853
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.